Reply
- PMID: 36102843
- DOI: 10.1097/DCR.0000000000002603
Reply
Comment on
-
Comment on: Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched, Population-Based Study in Catalonia, Spain.Dis Colon Rectum. 2022 Dec 1;65(12):e1079. doi: 10.1097/DCR.0000000000002602. Epub 2022 Sep 2. Dis Colon Rectum. 2022. PMID: 36102840 No abstract available.
References
-
- Ishiyama Y, Ito S, Amiki M, Hirano Y. Comment on: Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: a Propenssity Score Matched, population-based study in Catalonia, Spain. Dis Colon Rectum. 2022.
-
- Manchon-Walsh P, de Lacy FB, Pera M, et al. Transanal total mesorectal excision versus anterior total mesorectal excision for rectal cancer: a propensity score matched, population-based study in Catalonia, Spain. Dis Colon Rectum. 2022;65:207–217.
-
- Fleshman J, Branda ME, Sargent DJ, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg. 2019;269:589–595.
-
- Stevenson ARL, Solomon MJ, Brown CSB, et al.; Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT investigators. Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the Australasian laparoscopic cancer of the rectum randomized clinical trial. Ann Surg. 2019;269:596–602.
-
- Bonjer HJ, Deijen CL, Abis GA, et al.; COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372:1324–1332.
Publication types
LinkOut - more resources
Full Text Sources
